Eqrx Stock Price, News & Analysis

EQRX NASDAQ

Company Description

Eqrx (NASDAQ: EQRX) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

EQRX stock has declined 100.0% over the past year.

This page provides a comprehensive overview of EQRX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

487.7M

Shares outstanding

Eqrx (EQRX) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

May 8, 2023

-8.70%

EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results

earnings

April 27, 2023

-3.57%

EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023

conferences earnings

February 23, 2023

+1.38%

EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress

earnings

January 3, 2023

+1.22%

EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

conferences

December 19, 2022

-2.29%

EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer

December 2, 2022

+7.69%

EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer

Eqrx has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences. View all EQRX news →

SEC Filings

View All

No SEC filings available for EQRX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

EQRX Company Profile & Sector Positioning

Eqrx (EQRX) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.